A patient may be a candidate for GLP-1 weight loss if they have obesity, overweight with weight-related health concerns, insulin resistance, prediabetes, type 2 diabetes risk, high blood pressure, high cholesterol, fatty liver concerns, sleep apnea risk, or repeated difficulty losing and maintaining weight with lifestyle changes alone
Many people unintentionally skip meals because appetite simply doesnt speak up in the same familiar way
Noom GLP-1Rx addresses the biggest real-world problems with GLP-1s: poor persistence and lean muscle mass loss, Noom CEO Geoff Cook said in a statement
TLK286 clinical effects were investigated in the last decade in phase II and phase III trials for the treatment of drug-resistant ovarian cancer 112,113
For patients with decent pharmacy coverage, the math is less clear
Why Some Professionals Default to NAC or Glutathione Instead of Chelation Its understandable: most clinicians arent trained in pediatric chelation